Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-25

FDA Approved: RANOLAZINE — Original Application (Zameer Pharmaceuticals LLC)

View source ↗

Summary

FDA approves the original application for ranolazine from Zameer Pharmaceuticals LLC (ANDA213085), a generic antianginal drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)